Breast cancer susceptibility genes -: BRCA1 and BRCA2

被引:111
|
作者
Brody, LC
Biesecker, BB
机构
[1] Natl Human Genome Res Inst, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA
[2] Natl Human Genome Res Inst, Med Genet Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1097/00005792-199805000-00006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mutations in the BRCA1 and BRCA2, genes lead to an increased susceptibility to breast, ovarian, and other cancers. It is estimated that 3%-8% of all women with breast cancer will be found to carry a mutation in 1 of these genes. Families with multiple affected first-degree relatives and patients with early-onset disease have been found to harbor mutations at a higher frequency. The BRCA1 and BRCA2 genes code for large proteins that bear no resemblance to other known genes. In the cell, they appear to act as tumor suppressor genes and play a role in the maintenance of genome integrity, although the precise function of these genes has yet to be discovered. A large number of distinct mutations have been found in cancer families around the world. The majority of the defined pathologic mutations result in premature truncation of the protein (frameshift and nonsense mutations). These mutations may substantially increase the risk for breast and ovarian cancer, but a precise risk estimate for each different mutation cannot be determined. Depending on the familial context, the risk of breast cancer associated with carrying a mutation has been estimated to range from 50% to 85%. The role of these genes in sporadic cancer remains unknown. Patients and physicians considering BRCA1 and BRCA2 genetic testing are faced with a difficult decision. The diversity of mutations and lack of general population data prevent accurate risk prediction. This is further complicated by the paucity of data on effective prevention strategies for those identified at higher risk. Thus, the nature of clinical testing for BRCA1 and BRCA2 continues to present challenges that reinforce the necessity of personal choice within the context of thorough genetic counseling.
引用
收藏
页码:208 / 226
页数:19
相关论文
共 50 条
  • [21] BRCA1 and BRCA2 in hereditary breast cancer
    Scully, R
    Puget, N
    BIOCHIMIE, 2002, 84 (01) : 95 - 102
  • [22] Germline mutations in cancer susceptibility genes in brca1 and brca2 negative families with ovarian and breast cancer
    Norquist, B.
    Harrell, M.
    Walsh, T.
    Mandell, J.
    Agnew, K.
    Lee, M.
    Pennington, K.
    King, M. C.
    Swisher, E.
    GYNECOLOGIC ONCOLOGY, 2014, 135 (02) : 383 - 383
  • [23] BRCA2 AND BRCA1 breast cancer phenotypes
    Marcus, JN
    Watson, P
    Page, DL
    Narod, SA
    Tonin, P
    Serova, O
    Lenoir, GM
    Lynch, HT
    LABORATORY INVESTIGATION, 1997, 76 (01) : 110 - 110
  • [24] Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer
    Steinmann, D
    Bremer, M
    Rades, D
    Skawran, B
    Siebrands, C
    Karstens, JH
    Dörk, T
    BRITISH JOURNAL OF CANCER, 2001, 85 (06) : 850 - 858
  • [26] The Evolution, Functions and Applications of the Breast Cancer Genes BRCA1 and BRCA2
    Pfeffer, Claire M.
    Ho, Benjamin N.
    Singh, Amareshwar T. K.
    CANCER GENOMICS & PROTEOMICS, 2017, 14 (05) : 293 - 298
  • [27] Breast cancer genes: Behold BRCA1 protein and BRCA2 gene
    Gilgenkrantz, S
    M S-MEDECINE SCIENCES, 1996, 12 (6-7): : 812 - 814
  • [28] Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer
    D Steinmann
    M Bremer
    D Rades
    B Skawran
    C Siebrands
    J H Karstens
    T Dörk
    British Journal of Cancer, 2001, 85 : 850 - 858
  • [29] Mutations of the BRCA1 and BRCA2 genes in German breast cancer patients
    Skawran, B
    Bremer, M
    Stuhrmann, M
    Volkmann, C
    Schmidtke, J
    Karstens, JH
    Dörk, T
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 : 120 - 120
  • [30] The role of predisposing genes in breast cancer: BRCA1, BRCA2 and beyond
    Cortesi, Laura
    Federico, Massimo
    JOURNAL OF BIOTECHNOLOGY, 2014, 185 : S9 - S10